154 related articles for article (PubMed ID: 33840608)
1. Once daily tacrolimus conversion in lung transplantation: A prospective study on safety and medication adherence.
Godinas L; Dobbels F; Hulst L; Verbeeck I; De Coninck I; Berrevoets P; Schaevers V; Yserbyt J; Dupont LJ; Verleden SE; Vanaudenaerde BM; Ceulemans LJ; Van Raemdonck DE; Neyrinck A; Verleden GM; Vos R
J Heart Lung Transplant; 2021 Jun; 40(6):467-477. PubMed ID: 33840608
[TBL] [Abstract][Full Text] [Related]
2. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.
Doesch AO; Mueller S; Akyol C; Erbel C; Frankenstein L; Ruhparwar A; Ehlermann P; Dengler TJ; Katus HA
Drug Des Devel Ther; 2013; 7():1253-8. PubMed ID: 24174870
[TBL] [Abstract][Full Text] [Related]
3. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
[TBL] [Abstract][Full Text] [Related]
4. Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland.
Bonani M; Balaphas A; Bedino G; Bühler L; Dutkowski P; Fausch K; Gluderer S; Graf N; Hirt-Minkowski P; Müllhaupt B; Schönholzer C; Schulz MM; Venzin R; Wüthrich RP
Swiss Med Wkly; 2021 Feb; 151():w20453. PubMed ID: 33638353
[TBL] [Abstract][Full Text] [Related]
5. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden.
Fellström B; Holmdahl J; Sundvall N; Cockburn E; Kilany S; Wennberg L
Transplant Proc; 2018 Dec; 50(10):3275-3282. PubMed ID: 30577197
[TBL] [Abstract][Full Text] [Related]
6. Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study.
Oh CK; Bang JB; Kim SJ; Huh KH; Kim SJ; Jeon JS; Han SY; Cho HR; Kwon YJ; Lee SH; Kim YS
Asian J Surg; 2020 Jun; 43(6):660-667. PubMed ID: 31353239
[TBL] [Abstract][Full Text] [Related]
7. Trough Level and Tacrolimus Variability of Early Converted Once-Daily Tacrolimus: 1-Year Follow-up Study.
Sukkha S; Suansanae T; Iamrahong P; Wiwattanathum P
Transplant Proc; 2020 Apr; 52(3):775-779. PubMed ID: 32143870
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study.
Lehner LJ; Reinke P; Hörstrup JH; Rath T; Suwelack B; Krämer BK; Budde K; Banas B
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29052906
[TBL] [Abstract][Full Text] [Related]
9. Conversion From Twice-Daily to Once-Daily Tacrolimus Among Egyptian Living-Donor Kidney Allograft Recipients: A Single-Center Experience.
Bakr MA; Nagib AM; Abbas MH; Donia AF
Exp Clin Transplant; 2019 Oct; 17(5):594-598. PubMed ID: 31050617
[TBL] [Abstract][Full Text] [Related]
10. Renal function, efficacy and safety postconversion from twice- to once-daily tacrolimus in stable liver recipients: an open-label multicenter study.
Sańko-Resmer J; Boillot O; Wolf P; Thorburn D
Transpl Int; 2012 Mar; 25(3):283-93. PubMed ID: 22239105
[TBL] [Abstract][Full Text] [Related]
11. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients.
Bäckman L; Persson CA
Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379
[TBL] [Abstract][Full Text] [Related]
12. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.
Kuypers DR; Peeters PC; Sennesael JJ; Kianda MN; Vrijens B; Kristanto P; Dobbels F; Vanrenterghem Y; Kanaan N;
Transplantation; 2013 Jan; 95(2):333-40. PubMed ID: 23263559
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
14. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.
Coilly A; Calmus Y; Chermak F; Dumortier J; Duvoux C; Guillaud O; Houssel-Debry P; Neau-Cransac M; Stocco J
Liver Transpl; 2015 Oct; 21(10):1312-21. PubMed ID: 26264233
[TBL] [Abstract][Full Text] [Related]
15. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
[TBL] [Abstract][Full Text] [Related]
16. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.
Dumortier J; Guillaud O; Boillot O
Liver Transpl; 2013 May; 19(5):529-33. PubMed ID: 23483701
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation.
Méndez A; Berastegui C; López-Meseguer M; Monforte V; Bravo C; Blanco A; Camós S; Pou L; Roman A
Transplantation; 2014 Feb; 97(3):358-62. PubMed ID: 24492423
[TBL] [Abstract][Full Text] [Related]
18. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.
Kolonko A; Chudek J; Wiecek A
Transplant Proc; 2011 Oct; 43(8):2950-3. PubMed ID: 21996198
[TBL] [Abstract][Full Text] [Related]
19. Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting.
Valente G; Rinaldi L; Sgambato M; Piai G
Transplant Proc; 2013 Apr; 45(3):1273-5. PubMed ID: 23622676
[TBL] [Abstract][Full Text] [Related]
20. Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients.
Wu SW; Tsai HC; Tsai PY; Hung TW; Chang HR; Lian JD
Swiss Med Wkly; 2013; 143():w13850. PubMed ID: 23986367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
